Northstar RX Llc Pharmaceutical Import Profile — United States (DGFT 2022–2026)

Name: Northstar RX Llc Pharmaceutical Import Records from India — 4 Products, $1.6M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Northstar RX Llc — Pharmaceutical Importer Profile (2026) | 4 Products, $1.6M Trade | TransData Nexus

Northstar RX Llc

Pharmaceutical Importer · United States · Respiratory Focus · $1.6M Total Trade · DGFT Verified

Northstar RX Llc is a pharmaceutical importer based in United States with a total trade value of $1.6M across 4 products in 4 therapeutic categories. Based on 48 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Northstar RX Llc sources from 9 verified Indian suppliers, with Mankind Pharma Limited accounting for 24.2% of imports.

Northstar RX Llc — Import Portfolio & Supplier Network

Northstar RX Llc import network — 4 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Northstar RX Llc?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Mankind Pharma Limited	$701.7K	18	24.2%
Aspiro Pharma Limited	$600.9K	13	20.7%
Rubicon Research Limited

What Formulations Does Northstar RX Llc Import?

Formulation	Value	Ships
Daptomycin INJ	$134.9K	3
Daptomycin	$124.8K	3
Doxorubicin hydrochloride liposome	$100.0K	2
Daptomycin injection	$100.0K	2
Doxorubicin hydrochloride liposome injection 50MG/25ML 2MG/ML single dose vials	$100.0K	2
Fosaprepitant INJ	$100.0K	2
Formoterol fumarate inhalation solution,20mcg/2ML, Pack:carton contains:60x2ml unit dose vials net content (in grm)	$100.0K	2
Formoterol fumarate inhalation solution,20mcg/2ML, Pack:carton contains:60x2ml unit dose vials net content (in grm)	$100.0K	2
41168 clonazepam TAB USP 0.5MG 100 nor 72603-307-01	$88.8K	2
41169 clonazepam TAB USP 0.5MG 500 nor 72603-307-02	$85.1K	2
Clobazam 10MG tablet (12744x100's Pack)(cbn export auth. no. p-exp-15570/2023 valid up to 06.03.2024	$64.6K	3
41169clonazepam TAB USP 0 5mg500 nor72603 307 02econo	$52.1K	3
Fosaprepitant 150MG INJ (8528x1's Pack)	$50.0K	1
Fosaprepitant 150MG INJ (17479x1's Pack)	$50.0K	1
Fosaprepitant 150MG INJ (17970x1's Pack)	$50.0K	1

Northstar RX Llc imports 65 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 4 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Formoterol	Respiratory	$750.0K	15	1.3%	6
2	Clonazepam	CNS & Psychiatric	$474.0K	25	0.4%	6
3	Doxorubicin	Oncology	$250.0K	5	0.4%	11
4	Tobramycin	Antibiotics	$150.0K	3	0.4%	18

Northstar RX Llc imports 4 pharmaceutical products across 4 categories into United States totaling $1.6M.

Northstar RX Llc — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Northstar Rx LLC is a privately held pharmaceutical company headquartered in Memphis, Tennessee, United States. Established to provide cost-effective generic pharmaceutical products, Northstar Rx LLC operates as an importer and distributor, focusing on sourcing medications from international manufacturers to meet the needs of the U.S. market. The company is not a subsidiary of any parent organization, allowing it to maintain independent operations within the pharmaceutical distribution sector. Northstar Rx LLC plays a significant role in the U.S. pharmaceutical supply chain by ensuring the availability of affordable generic drugs, thereby contributing to the overall accessibility of healthcare in the country.

2Distribution Network

Northstar Rx LLC's distribution network is strategically designed to ensure efficient delivery of pharmaceutical products across the United States. The company operates multiple warehouse locations, including facilities in Memphis, Tennessee, and Mason, Ohio, which serve as central hubs for inventory management and order fulfillment. These locations are equipped with advanced logistics capabilities, enabling the company to handle a diverse range of pharmaceutical products and meet the demands of various healthcare providers. Geographically, Northstar Rx LLC's distribution network covers the entire U.S., ensuring timely and reliable delivery to retail pharmacies, hospitals, and other healthcare facilities nationwide.

3Industry Role

In the United States pharmaceutical supply chain, Northstar Rx LLC functions primarily as a pharmaceutical importer and distributor. By sourcing generic medications from international manufacturers, the company enhances the availability of affordable pharmaceutical options within the U.S. market. This role is crucial in addressing the demand for cost-effective medications, particularly in therapeutic areas where generic alternatives are essential for patient care. Through its importation and distribution activities, Northstar Rx LLC contributes to the diversification and resilience of the U.S. pharmaceutical supply chain.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Northstar RX Llc

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Northstar Rx LLC's sourcing strategy exhibits a high degree of concentration, with a significant portion of its pharmaceutical imports originating from India. The company's total import value from India amounts to $1.6 million USD, encompassing 48 shipments across four therapeutic categories. This concentration indicates a strategic choice to leverage India's robust pharmaceutical manufacturing capabilities, which are recognized for producing high-quality generic medications. However, such dependency on a single source country introduces potential risks, including exposure to geopolitical tensions, regulatory changes, and supply chain disruptions. The shipment data reveals a stable relationship with Indian suppliers, as evidenced by the consistent flow of imports over the years. Nonetheless, the lack of diversification in sourcing could pose challenges in the event of unforeseen disruptions in the Indian pharmaceutical sector.

2Supply Chain Resilience

The resilience of Northstar Rx LLC's supply chain is closely tied to its reliance on Indian pharmaceutical manufacturers. While the company has established relationships with multiple suppliers, including Mankind Pharma Limited, Aspiro Pharma Limited, and Rubicon Research Limited, the overall supply chain remains vulnerable to disruptions within India. The absence of backup suppliers outside of India further exacerbates this risk, as alternative sourcing options are limited. Additionally, the concentration of shipments through specific ports, such as Jawaharlal Nehru and Mundra in India, exposes the supply chain to potential bottlenecks or delays at these critical transit points. Regulatory compliance among key suppliers is essential; however, without detailed information on each supplier's adherence to international standards, the overall supply chain's resilience cannot be fully assessed.

Importing Pharmaceuticals into United States — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United States

1Regulatory Authority & Framework

In the United States, the Food and Drug Administration (FDA) serves as the primary regulatory authority overseeing the importation and distribution of pharmaceutical products. The FDA enforces stringent regulations to ensure that all imported drugs meet the same standards for quality, safety, and effectiveness as those produced domestically. Key legislation governing pharmaceutical imports includes the Federal Food, Drug, and Cosmetic Act, which outlines the requirements for drug approval, labeling, and manufacturing practices. The FDA's Center for Drug Evaluation and Research (CDER) is responsible for evaluating new drug applications and ensuring that imported drugs comply with U.S. standards. For Indian generics to be marketed in the U.S., they must undergo the FDA's Abbreviated New Drug Application (ANDA) process, demonstrating bioequivalence to the reference listed drug.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products entering the U.S. are governed by the FDA. All foreign manufacturers must register with the FDA and list their products before importing. Good Manufacturing Practice (GMP) certification is mandatory, ensuring that drugs are produced in facilities adhering to quality standards. The FDA recognizes GMP certifications from various international bodies, including the World Health Organization (WHO) and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Indian pharmaceutical manufacturers seeking to export to the U.S. must obtain FDA approval for their facilities and products, demonstrating compliance with these GMP standards. Additionally, wholesale distribution authorization is required for entities involved in the distribution of pharmaceutical products within the U.S., ensuring that all intermediaries in the supply chain meet regulatory standards.

Northstar RX Llc — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Northstar Rx LLC's focus on importing generic medications in the respiratory, central nervous system (CNS) and psychiatric, and oncology therapeutic categories aligns with significant market demand in the United States. The respiratory category, accounting for 46.2% of imports, addresses the widespread need for treatments for conditions such as asthma and chronic obstructive pulmonary disease (COPD). The CNS and psychiatric category (29.2%) reflects the high prevalence of mental health disorders and neurological conditions, necessitating accessible treatment options. Oncology products (15.4%) cater to the ongoing demand for cancer therapies, as cancer remains a leading cause of morbidity and mortality in the U.S. By concentrating on these therapeutic areas, Northstar Rx LLC effectively meets critical healthcare needs and positions itself as a key player in providing essential medications.

2Sourcing Profile

Northstar Rx LLC's sourcing strategy emphasizes the procurement of generic drugs from Indian manufacturers, capitalizing on India's established reputation for producing high-quality, cost-effective pharmaceuticals. The company's portfolio includes a diverse range of formulations, with 65 unique products imported from India. This approach allows Northstar Rx LLC to offer a comprehensive selection of medications across various therapeutic categories, ensuring a steady supply of essential drugs to the U.S. market. By maintaining a diversified sourcing profile, the company mitigates risks associated with supply chain disruptions and regulatory changes in any single source country.

Seller's Guide — How to Become a Supplier to Northstar RX Llc

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to collaborate with Northstar Rx LLC, particularly in therapeutic areas where the company seeks to expand its product offerings. Identifying gaps in Northstar Rx LLC's current sourcing, such as specific formulations or dosage forms not currently imported, presents avenues for potential partnerships. Indian exporters can leverage this opportunity by ensuring compliance with FDA regulations, maintaining high-quality manufacturing standards, and demonstrating the ability to meet the logistical demands of the U.S. market. Establishing such

TransData Nexus Research · Industry procurement practicesMar 2026

Frequently Asked Questions — Northstar RX Llc

What products does Northstar RX Llc import from India?

Northstar RX Llc imports 4 pharmaceutical products across 4 categories. Top imports: Formoterol ($750.0K), Clonazepam ($474.0K), Doxorubicin ($250.0K), Tobramycin ($150.0K).

Who supplies pharmaceuticals to Northstar RX Llc from India?

Northstar RX Llc sources from 9 verified Indian suppliers. The primary supplier is Mankind Pharma Limited (24.2% of imports, $701.7K).

What is Northstar RX Llc's total pharmaceutical import value?

Northstar RX Llc's total pharmaceutical import value from India is $1.6M, based on 48 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Northstar RX Llc focus on?

Northstar RX Llc imports across 4 categories. The largest: Respiratory (46.2%), CNS & Psychiatric (29.2%), Oncology (15.4%).

Get Full Northstar RX Llc Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.